{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:46:10Z","timestamp":1792097170372,"version":"4.4.0"},"reference-count":0,"publisher":"American Society of Hematology","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Preeclampsia (PE) is associated with enhanced platelet activation, with thromboxane A\u2082 playing a key pathogenic role. Urinary 11-dehydro-thromboxane B\u2082 (TXM) reflects in vivo platelet activation. Although low-dose aspirin (ASA) is recommended for PE prevention in high-risk pregnancies, variable thromboxane suppression may lead to persistent platelet activation. This study aimed at identifying platelet-derived predictors of PE in high-risk women receiving ASA and assessing biomarkers improving risk stratification. This observational study included 25 high-risk pregnant women on ASA and 12 with physiological pregnancies. Clinical evaluation and blood\/urine sampling were performed at baseline (T0), and at 21 (T4) and 27 (T5) weeks. Urinary TXM and percentage inhibition (&amp;lt;75% = reduced inhibition) were assessed. Platelet biomarkers included thrombopoietin (TPO), glycocalicin (GC), P-selectin, and CD40L. Late-onset PE occurred in 6\/25 (24%) high-risk women and in none of the controls. TXM levels were higher in high-risk versus physiological pregnancies (p=0.009), especially at T4-T5 (p&amp;lt;0.0001). Women developing PE had higher TXM at T4 (adjusted p=0.014) and lower TXM inhibition (51% vs 81%; p=0.020). Reduced inhibition (&amp;lt;75%) was associated with increased PE risk (44.4% vs 14.3%; OR 4.8). TPO showed a different longitudinal pattern according to PE occurrence (time-by-outcome interaction p=0.036). Glycocalicin showed higher estimated values at baseline in women who developed PE (p=0.048), but the time-specific contrast was attenuated after Holm adjustment (adjusted p=0.19). Incomplete thromboxane suppression during ASA therapy is associated with PE. TXM, together with opposite trends of TPO and GC, identifies a profile consistent with altered platelet homeostasis and possible changes in platelet turnover, potentially enhancing risk prediction in high-risk pregnancies.<\/jats:p>","DOI":"10.1182\/bloodadvances.2026021230","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:09:58Z","timestamp":1792094998000},"update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Persistent Thromboxane Biosynthesis Despite Aspirin Therapy Predicts Preeclampsia"],"prefix":"10.1182","author":[{"given":"Paola G","family":"Simeone","sequence":"first","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Liani","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-3148","authenticated-orcid":false,"given":"Margherita","family":"Alfonsetti","sequence":"additional","affiliation":[{"name":"University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessa","family":"Ricci","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Cianci","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1656-9416","authenticated-orcid":false,"given":"Zeeba","family":"Saeed","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Molino","sequence":"additional","affiliation":[{"name":"Clinical Pathology, SS. Annunziata Hospital, Chieti, Italy, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3331-5458","authenticated-orcid":false,"given":"Stefano","family":"Palma","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raniero","family":"Malizia","sequence":"additional","affiliation":[{"name":"SS. Annunziata Hospital, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Luongo","sequence":"additional","affiliation":[{"name":"SS. Annunziata Hospital, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-7998","authenticated-orcid":false,"given":"Augusto","family":"Di Castelnuovo","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Pozzilli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-4851","authenticated-orcid":false,"given":"Sabina","family":"Gallina","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Idaho, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cipollone","sequence":"additional","affiliation":[{"name":"Clinina Medica, Department of Medicine and Aging Sciences, Chieti Scalo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1401-6623","authenticated-orcid":false,"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-8386","authenticated-orcid":false,"given":"Giulia","family":"Renda","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D'Antonio","sequence":"additional","affiliation":[{"name":"University of Chieti \"G.d'Annunzio\", Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-905X","authenticated-orcid":false,"given":"Francesca","family":"Santilli","sequence":"additional","affiliation":[{"name":"Center for Advanced Studies and Technology (CAST), University of Chieti-Pescara G. d'Annunzio, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,15]]},"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2026021230\/2595534\/bloodadvances.2026021230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2026021230\/2595534\/bloodadvances.2026021230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:09:58Z","timestamp":1792094998000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/doi\/10.1182\/bloodadvances.2026021230\/571581\/Persistent-Thromboxane-Biosynthesis-Despite"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026021230","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"article-number":"bloodadvances.2026021230"}}